Abstract:CRISPR-Cas systems are widely used for genome engineering technologies, and in their natural setting, they play crucial roles in bacterial and archaeal adaptive immunity, protecting against phages and other mobile genetic elements. Previously we discovered bacteriophage-encoded Cas9-specific anti-CRISPR (Acr) proteins that serve as countermeasures against host bacterial immunity by inactivating their CRISPR-Cas systems 1 . We hypothesized that the evolutionary advantages conferred by anti-CRISPRs would drive the widespread occurrence of these proteins in nature 2–4 . We have identified new anti-CRISPRs using the bioinformatic approach that successfully identified previous Acr proteins 1 against Neisseria meningitidis Cas9 (NmeCas9). In this work we report two novel anti-CRISPR families in strains of Haemophilus parainfluenzae and Simonsiella muelleri , both of which harbor type II-C CRISPR-Cas systems 5 . We characterize the type II-C Cas9 orthologs from H. parainfluenzae and S. muelleri , show that the newly identified Acrs are able to inhibit these systems, and define important features of their inhibitory mechanisms. The S. muelleri Acr is the most potent NmeCas9 inhibitor identified to date. Although inhibition of NmeCas9 by anti-CRISPRs from H. parainfluenzae and S. muelleri reveals cross-species inhibitory activity, more distantly related type II-C Cas9s are not inhibited by these proteins. The specificities of anti-CRISPRs and divergent Cas9s appear to reflect co-evolution of their strategies to combat or evade each other. Finally, we validate these new anti-CRISPR proteins as potent off-switches for Cas9 genome engineering applications.

Inhibition of Type III CRISPR-Cas Immunity by an Archaeal Virus-Encoded Anti-CRISPR Protein

Molecular Basis for Inhibition of Type Iii-B Crispr-Cas by an Archaeal Viral Anti-Crispr Protein

An archaeal virus-encoded anti-CRISPR protein inhibits type III-B immunity by inhibiting Cas RNP complex turnover

AcrIIIA1 is a protein-RNA anti-CRISPR complex that targets core Cas and accessory nucleases

Multilayered interaction between CRISPR-Cas subtype I-A and adjacently encoded Acrs of virus SIRV2

Diverse viral cas genes antagonize CRISPR immunity

A phage-encoded anti-CRISPR enables complete evasion of type VI-A CRISPR-Cas immunity

Molecular Mechanisms Of Iii-B Crispr-Cas Systems In Archaea

Structural basis for inhibition of an archaeal CRISPR–Cas type I-D large subunit by an anti-CRISPR protein

Tolerance of Sulfolobus SMV1 Virus to the Immunity of I-A and III-B CRISPR-Cas Systems in Sulfolobus Islandicus

Broad-spectrum enzymatic inhibition of CRISPR-Cas12a

Structural Basis for AcrVA4 Inhibition of Specific CRISPR-Cas12a

Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins

An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference.

AcrVIB1 inhibits CRISPR-Cas13b immunity by promoting unproductive crRNA binding accessible to RNase attack

Mechanistic insights into the inhibition of the CRISPR-Cas surveillance complex by anti-CRISPR protein AcrIF13

Potent Cas9 inhibition in bacterial and human cells by new anti-CRISPR protein families

Cas9 Allosteric Inhibition by the Anti-CRISPR Protein AcrIIA6

Lack of Cas13a inhibition by anti-CRISPR proteins from Leptotrichia prophages

An anti-CRISPR protein disables type V Cas12a by acetylation

Structural and biochemical insights into the mechanism of the anti-CRISPR protein AcrIE3